Sleep Apnea
Sleep Apnea
Sleep apnea is a medical disorder characterized by frequent interruptions in breathing of up to ten seconds or more during sleep. The condition is associated with numerous physiological disorders, including fatigue, headaches, high blood pressure, irregular heartbeat, heart attack and stroke.
Though sleep apnea often goes undiagnosed, it is estimated that approximately four percent of men and two percent of women ages 30 to 60 years old suffer from the disease.
One preclinical study is cited in the scientific literature investigating the role of cannabinoids on sleep-related apnea. Writing in the June 2002 issue of the journal of the American Academy of Sleep Medicine, researchers at the University of Illinois (at Chicago) Department of Medicine reported "potent suppression" of sleep-related apnea in rats administered either exogenous or endogenous cannabinoids.
[1] Investigators reported that doses of delta-9-THC and the endocannabinoid oleamide each stabilized respiration during sleep and blocked serotonin-induced exacerbation of sleep apnea in a statistically significant manner. No follow up investigations have taken place assessing the use of cannabinoids to treat this indication. However, several recent preclinical and clinical trials have reported on the use of THC, natural cannabis extracts and endocannabinoids to induce sleep[2-3] and/or improve sleep quality.[4]
REFERENCES
[1] Carley et al. 2002. Functional role for cannabinoids in respiratory stability during sleep. Sleep 25: 399-400.
[2] Murillo-Rodriguez et al. 2003. Anandamide enhances extracellular levels of adenosine and induces sleep: an in vivo microdialysis study. Sleep 26: 943-947.
[3] Nicholson et al. 2004. Effect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. Journal of Clinical Pharmacology 24: 305-313.
[4] Christine Perras. 2005. Sativex for the management of multiple sclerosis symptoms. Issues in Emerging Health Technologies 72: 1-4
Related News Items
No documents found.
Recommended Doctors
No documents found.
CPN Interviews Suzanne Jones of Missouri
Suzanne's misdiagnosis almost claimed her life. The seemingly endless flow of pharmaceuticals only exacerbated her fragile condition. Her form of cancer, Systemic Mastocytosis, seemed hopeless to treat until she discovered cannabis.
CPN Interviews Kathleen Wolff of Missouri
In July of 1993, Kathleen's life changed forever when her car was struck from behind. Suffering a traumatic brain injury (TBI), Kathleen seemed trapped between her debilitating condition and the pharmaceuticals that sapped her humanity in exchange for temporary relief.
CPN Interviews Heath Poland of Missouri
Heath suffers from ADHD (Attention Deficit Disorder) and Bipolar Disorder. Like so many who suffer from mental illness, he spent much of his life mis-diagnosed and improperly and/or over-medicated.
CPN Interviews Greg Terry of Missouri
Ever since Greg was 17, he has battled Crohn's Disease, Though he has run the gamut of of surgeries and pharmaceutical meds to treat this debilitating disease, only one holistic treatment has given him lasting relief from his symptoms. So, for 34 years, Cannabis has been his medicine of choice.
CPN Interviews Cory Harlan of Missouri
Cory has suffered greatly in his 29 years. Because of a traumatic brain injury (TBI) as an infant, he developed a condition called Mesial Temporal Sclerosis. He has been in and out of hospitals and institutions ever since. Cannabis relieves his pain and seizures and has helped him return to college.
CPN Interviews Brian Chitwood of Missouri
I first met Brian at the 2009 Joplin Cannabis Revival. Brian is a Hodgkin's Lymphoma survivor. He attributes his recovery to his use of cannabis as an adjunct to the chemotherapy he received.
Signup for Updates
Stay informed about recent news, upcoming events, and more!